Arginine Vasopressin vs NPY

Head-to-head comparison of Arginine Vasopressin (8-Arginine Vasopressin) and NPY (Neuropeptide Y) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArginine VasopressinNPY
CategoryCognitive EnhancementCognitive Enhancement
Full Name8-Arginine VasopressinNeuropeptide Y
Molecular Weight1084.23 Da4272 Da
Half-Life10-20 minutesminutes
Amino Acids936 aa
Typical Dose10-40 IU intranasal research range1-10 µg preclinical range
RouteIntranasal/SubcutaneousIntranasal
Purity≥98%≥98%
Studies Count100900
Research StatusClinicalPre-clinical

Arginine Vasopressin Benefits

  • memory consolidation
  • recall support
  • arousal-linked learning
  • social cognition

NPY Benefits

  • stress resilience
  • hippocampal protection
  • memory modulation
  • anti-excitotoxic signaling

Arginine Vasopressin Dosing

intranasal research dosing|10-40 IU per dose in studies|single or repeated administration

NPY Dosing

0.1-1 nmol ICV in rodents|1-10 µg intranasal in experimental work|acute or repeated stress-model protocols

Arginine Vasopressin Side Effects

  • blood pressure elevation
  • headache
  • hyponatremia

NPY Side Effects

  • sedation
  • appetite increase
  • blood pressure changes

Research Overview

Arginine Vasopressin

Animal and human studies indicate vasopressin can modulate hippocampal and limbic circuits involved in learning and memory. The effect size is context dependent, and results vary by dose, route, and baseline cognitive state.

NPY

NPY has been shown in animal studies to protect neurons from excitotoxic injury and to dampen stress-linked cognitive impairment. It is often discussed as a counterbalance to overactive glutamatergic and stress pathways in the brain.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Arginine Vasopressin stacks with:

gpenoopeptdesmopressin

NPY stacks with:

magnesium-threonateciticolinebacopa
nonapeptidememoryneuropeptidestresshippocampusneuroprotection